傲农生物 - Financials

傲农生物 — Financial Statements

Annual Quarterly

5 10 All

Income Statement

Balance Sheet

Cash Flow

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013
+Revenue	8.8B	19.5B	21.6B	18.0B	11.5B	5.8B	5.8B	4.9B	5.0B	4.0B	4.2B	3.0B
Revenue Growth %	-55.0%	-10.0%	19.8%	56.6%	99.0%	0.5%	17.5%	-1.5%	24.0%	-4.1%	41.6%	--
Total Revenue	8.8B	19.5B	21.6B	18.0B	11.5B	5.8B	5.8B	4.9B	5.0B	4.0B	4.2B	3.0B
Cost Of Revenue	8.4B	20.4B	20.7B	17.8B	9.5B	5.1B	5.0B	4.0B	4.1B	3.3B	3.5B	2.5B
+Gross Profit	396.0M	-922.0M	948.0M	257.0M	2.0B	737.0M	789.0M	925.0M	871.0M	753.0M	675.0M	459.0M
Gross Margin %	4.5%	-4.7%	4.4%	1.4%	17.3%	12.7%	13.7%	18.9%	17.5%	18.8%	16.1%	15.5%
Total Operating Cost	10.5B	23.1B	22.9B	19.8B	10.6B	5.7B	5.8B	4.8B	4.9B	4.0B	4.2B	2.9B
Selling Expenses	264.0M	360.0M	413.0M	338.0M	247.0M	253.0M	403.0M	451.0M	465.0M	414.0M	445.0M	286.0M
Admin Expenses	870.0M	714.0M	664.0M	609.0M	432.0M	196.0M	153.0M	165.0M	254.0M	260.0M	179.0M	126.0M
Rd Expenses	54.5M	149.0M	162.0M	114.0M	65.4M	72.9M	110.0M	107.0M	--	--	--	--
Finance Expenses	654.0M	570.0M	532.0M	432.0M	179.0M	94.2M	70.4M	40.3M	25.4M	19.1M	11.3M	4.9M
+Operating Income	417.0M	-3.6B	-1.3B	-1.8B	966.0M	78.1M	21.6M	149.0M	113.0M	51.6M	32.4M	35.5M
Operating Margin %	4.8%	-18.8%	-6.1%	-10.0%	8.4%	1.3%	0.4%	3.0%	2.3%	1.3%	0.8%	1.2%
Non Operating Income	31.3M	69.1M	61.6M	38.7M	40.5M	8.1M	6.5M	4.2M	11.2M	5.8M	12.7M	609,400
Non Operating Expenses	364.0M	101.0M	45.2M	53.6M	35.6M	8.4M	8.2M	4.6M	4.0M	2.5M	293,200	577,800
Investment Income	2.0B	-5.7M	-14.4M	-28.5M	5.9M	-6.9M	1.7M	2.3M	-837,700	-353,000	-1.4M	-1.7M
Fair Value Change Income	-26.9M	1.6M	-105.0M	-31.5M	-23.7M	--	--	--	--	--	--	--
Asset Disposal Income	46.2M	-38.3M	2.6M	-2.4M	-3.8M	-603,100	-242,600	-470,600	-1.8M	--	--	--
Asset Impairment Loss	138.0M	846.0M	330.0M	457.0M	6.6M	938,500	33.5M	15.7M	5.7M	7.8M	6.3M	4.1M
Other Income	75.1M	65.6M	73.2M	34.1M	29.5M	15.1M	10.1M	9.8M	--	--	--	--
Income Before Tax	84.5M	-3.7B	-1.3B	-1.8B	971.0M	77.7M	19.9M	149.0M	121.0M	54.8M	44.9M	35.6M
Income Tax	21.4M	87.1M	-69.2M	29.3M	-23.1M	-22.6M	9.6M	26.7M	12.2M	16.2M	5.7M	12.0M
+Net Income	63.1M	-3.8B	-1.2B	-1.9B	994.0M	100.0M	10.2M	122.0M	108.0M	38.7M	39.2M	23.5M
Net Margin %	0.7%	-19.4%	-5.7%	-10.3%	8.6%	1.7%	0.2%	2.5%	2.2%	1.0%	0.9%	0.8%
Net Income Attributable	579.0M	-3.7B	-1.0B	-1.5B	573.0M	29.2M	30.1M	108.0M	91.4M	33.8M	42.7M	25.0M
Minority Interest	-516.0M	-118.0M	-187.0M	-331.0M	421.0M	71.2M	-19.9M	14.0M	17.0M	4.9M	-3.5M	-1.5M
Eps Basic	0.67	-4.21	-1.34	-2.34	0.95	0.05	0.07	0.29	0.25	0.10	--	--
Eps Diluted	0.67	-4.21	-1.34	-2.23	0.91	0.05	0.07	--	--	--	--	--

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013
Cash And Equivalents	1.4B	208.0M	719.0M	543.0M	571.0M	255.0M	171.0M	229.0M	174.0M	193.0M	88.6M	130.0M
Trading Financial Assets	1.8M	4.6M	2.6M	1.0M	1.4M	--	--	--	--	--	--	--
Accounts Receivable	393.0M	648.0M	515.0M	527.0M	449.0M	427.0M	482.0M	342.0M	265.0M	267.0M	163.0M	98.8M
Notes Receivable	--	2.9M	--	135,200	--	8.3M	9.3M	3.1M	2.5M	5.7M	3.0M	3.1M
Notes And Accounts Receivable	393.0M	651.0M	515.0M	527.0M	449.0M	435.0M	491.0M	345.0M	268.0M	273.0M	166.0M	102.0M
Prepayments	174.0M	239.0M	320.0M	311.0M	427.0M	81.3M	30.1M	56.1M	41.0M	23.6M	18.8M	22.1M
Inventory	817.0M	1.3B	3.3B	2.6B	1.7B	599.0M	433.0M	392.0M	285.0M	243.0M	242.0M	233.0M
Total Current Assets	3.7B	2.8B	5.1B	4.3B	3.5B	1.5B	1.2B	1.2B	802.0M	751.0M	555.0M	502.0M
Long Term Equity Investment	126.0M	249.0M	251.0M	160.0M	177.0M	50.9M	39.1M	19.0M	17.4M	6.0M	5.3M	6.3M
Fixed Assets	--	5.9B	6.3B	5.7B	4.0B	1.7B	1.2B	719.0M	550.0M	331.0M	167.0M	109.0M
Fixed Assets Total	3.4B	5.9B	6.3B	5.7B	4.0B	1.7B	1.2B	719.0M	550.0M	331.0M	167.0M	109.0M
Construction In Progress	--	954.0M	1.2B	1.3B	1.5B	718.0M	296.0M	233.0M	51.5M	60.2M	31.9M	14.0M
Construction In Progress Total	474.0M	954.0M	1.2B	1.3B	1.5B	718.0M	296.0M	233.0M	51.5M	60.2M	31.9M	14.0M
Intangible Assets	329.0M	424.0M	651.0M	463.0M	374.0M	207.0M	177.0M	143.0M	99.6M	72.5M	43.4M	17.3M
Long Term Deferred Expenses	160.0M	336.0M	354.0M	321.0M	414.0M	151.0M	106.0M	60.5M	26.2M	22.2M	21.6M	10.9M
Total Non Current Assets	5.8B	10.8B	13.5B	12.8B	8.5B	3.4B	2.1B	1.4B	910.0M	597.0M	372.0M	208.0M
Total Assets	9.5B	13.6B	18.7B	17.1B	12.0B	4.9B	3.3B	2.5B	1.7B	1.3B	927.0M	710.0M
Short Term Borrowings	765.0M	3.8B	4.0B	3.7B	2.7B	1.2B	925.0M	413.0M	237.0M	208.0M	176.0M	57.5M
Accounts Payable	1.7B	3.4B	4.0B	3.7B	2.1B	1.3B	726.0M	540.0M	491.0M	476.0M	355.0M	373.0M
Advance Receipts	--	--	--	--	--	59.9M	25.4M	35.0M	38.9M	41.8M	15.7M	9.8M
Contract Liabilities	172.0M	328.0M	253.0M	262.0M	212.0M	--	--	--	--	--	--	--
Total Current Liabilities	4.6B	11.4B	11.6B	10.1B	6.2B	3.4B	2.0B	1.2B	951.0M	872.0M	698.0M	604.0M
Long Term Borrowings	1.5B	1.2B	1.6B	2.1B	1.4B	14.0M	212.0M	256.0M	90.0M	--	--	--
Total Non Current Liabilities	1.8B	2.8B	3.6B	4.8B	1.9B	256.0M	315.0M	345.0M	167.0M	31.3M	13.8M	--
Total Liabilities	6.4B	14.1B	15.2B	14.9B	8.1B	3.6B	2.3B	1.6B	1.1B	903.0M	712.0M	604.0M
Paid In Capital	2.6B	870.0M	871.0M	684.0M	674.0M	434.0M	426.0M	420.0M	360.0M	300.0M	100.0M	67.0M
Capital Reserve	5.0B	3.8B	3.7B	1.5B	1.5B	257.0M	218.0M	195.0M	28.2M	27.5M	15.5M	9.2M
Surplus Reserve	68.4M	68.4M	68.4M	68.4M	65.9M	21.1M	20.4M	18.2M	15.0M	3.0M	--	--
Retained Earnings	-5.0B	-5.6B	-2.0B	-936.0M	689.0M	213.0M	188.0M	175.0M	69.9M	50.5M	55.2M	17.5M
Minority Equity	495.0M	460.0M	929.0M	890.0M	1.2B	456.0M	195.0M	157.0M	121.0M	64.3M	44.3M	12.7M
Equity Attributable	2.6B	-963.0M	2.5B	1.3B	2.7B	828.0M	814.0M	808.0M	473.0M	381.0M	171.0M	93.6M
Total Equity	3.1B	-503.0M	3.4B	2.2B	3.9B	1.3B	1.0B	966.0M	594.0M	445.0M	215.0M	106.0M

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013
Cash From Sales	8.5B	19.5B	21.8B	18.2B	11.7B	5.8B	5.6B	4.8B	5.0B	3.9B	4.1B	2.9B
Tax Refunds Received	--	--	--	1.0M	223,500	143,900	304,200	40,900	--	--	--	--
Total Operating Cash Inflow	9.6B	22.0B	22.2B	18.7B	12.2B	6.0B	5.7B	4.9B	5.1B	4.0B	4.2B	3.0B
Cash Paid For Goods	7.2B	16.9B	19.3B	16.1B	10.3B	4.8B	4.8B	3.9B	4.0B	3.1B	3.5B	2.3B
Cash Paid To Employees	862.0M	1.4B	1.5B	1.3B	684.0M	422.0M	459.0M	419.0M	398.0M	329.0M	288.0M	165.0M
Taxes Paid	69.4M	108.0M	99.9M	86.4M	40.5M	24.6M	43.9M	34.4M	37.1M	25.5M	35.8M	19.6M
Total Operating Cash Outflow	9.7B	21.0B	21.5B	18.1B	11.8B	5.6B	5.7B	4.8B	4.9B	3.9B	4.2B	2.8B
Operating Cash Flow	-117.0M	984.0M	664.0M	524.0M	406.0M	394.0M	27.3M	41.9M	129.0M	129.0M	-33.7M	137.0M
Total Investing Cash Inflow	241.0M	367.0M	278.0M	670.0M	111.0M	18.8M	123.0M	3.2M	14.0M	3.7M	5.1M	5,000
Total Investing Cash Outflow	280.0M	689.0M	2.0B	3.5B	4.1B	746.0M	671.0M	569.0M	334.0M	221.0M	165.0M	79.8M
Investing Cash Flow	-39.1M	-322.0M	-1.7B	-2.8B	-4.0B	-727.0M	-547.0M	-566.0M	-320.0M	-218.0M	-159.0M	-79.7M
Cash From Borrowings	524.0M	5.5B	5.6B	5.2B	4.4B	1.4B	1.0B	676.0M	411.0M	282.0M	199.0M	62.9M
Dividends And Interest Paid	110.0M	331.0M	374.0M	432.0M	403.0M	86.6M	76.6M	32.2M	17.8M	42.8M	11.9M	4.2M
Debt Repayments	894.0M	5.7B	5.2B	3.5B	1.9B	1.2B	521.0M	332.0M	286.0M	251.0M	80.3M	29.4M
Total Financing Cash Inflow	2.7B	7.7B	8.2B	7.2B	6.8B	1.9B	1.2B	1.0B	551.0M	531.0M	315.0M	79.1M
Total Financing Cash Outflow	1.6B	8.8B	7.0B	5.0B	2.9B	1.4B	700.0M	456.0M	403.0M	344.0M	164.0M	57.4M
Financing Cash Flow	1.1B	-1.1B	1.2B	2.2B	3.9B	404.0M	461.0M	571.0M	148.0M	186.0M	151.0M	21.7M
Net Change In Cash	980.0M	-470.0M	179.0M	-82.5M	328.0M	70.7M	-58.4M	47.9M	-42.6M	97.9M	-42.3M	79.2M
Ending Cash Balance	1.1B	152.0M	623.0M	444.0M	527.0M	198.0M	127.0M	186.0M	138.0M	180.0M	82.5M	125.0M
Capex	263.0M	512.0M	1.5B	2.7B	3.3B	658.0M	569.0M	440.0M	276.0M	206.0M	157.0M	72.8M